Sponsor Deadline:
Jul 7, 2023
Letter of Intent Deadline:
Jun 8, 2023
Sponsor:
Department of Defense/CDMRP
UI Contact:
Updated Date:
Mar 20, 2023
View the announcements for three upcoming programs
Applications submitted to the FY23 TSCRP must address one or more of the following Focus Areas:
- Understanding, preventing, and treating the features of TSC-Associated Neuropsychiatric Disorders (TAND) and reducing their impact, including pharmacological, behavioral, and surgical interventions
- Strategies for eradicating tumors associated with TSC and TSC-associated lymphangioleiomyomatosis (LAM), including gaining a deeper mechanistic understanding of tumor microenvironment, TSC signaling and mTOR-independent pathways
- Preventing, epilepsy, improving treatment, and mitigating neurodevelopmental and adverse outcomes associated with TSC-related seizures
- Developing, assessing, and testing emerging technologies including imaging and molecular therapeutic strategies, such as gene therapy, to improve outcomes in TSC